InvestorsHub Logo
Followers 2
Posts 129
Boards Moderated 0
Alias Born 03/16/2017

Re: moxa1 post# 85618

Wednesday, 04/19/2017 1:32:09 AM

Wednesday, April 19, 2017 1:32:09 AM

Post# of 203913
I imagine another good way to valuate a pre revenue biotech company would be to compare and contrast the 10k with other pre revenue biotech companies maybe trading around a similar pps. 80% of owcps 10k was legal jargon to protect from an unforeseeable future. Most 10ks I have looked at on the otc contain identical or at least similar layouts, all containing these bleak what-if outlooks. Is it possible owcp collapses tomorrow? Yes so they warn shareholders of the possibility. Is dilution possible? Yes, just as it is for every other company so it's mentioned just in case.

Anyway, I would like to do some comparative research. Anybody know of any other biotech contenders that we can line up against owcp so we can try and discover how well they're actually doing at their current business stage?